Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis

Author:

Shoop-Worrall Stephanie J. W.1,Verstappen Suzanne M. M.1,McDonagh Janet E.1,Baildam Eileen2,Chieng Alice3,Davidson Joyce45,Foster Helen67,Ioannou Yiannis8,McErlane Flora9,Wedderburn Lucy R.1011,Thomson W.1,Hyrich Kimme L.1

Affiliation:

1. The University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre; Manchester UK

2. Alder Hey Children's NHS Foundation Trust; Liverpool UK

3. Royal Manchester Children's Hospital; Manchester UK

4. The Royal Hospital for Children, Glasgow, UK; Edinburgh UK

5. The Royal Hospital for Sick Children; Edinburgh UK

6. Great North Children's Hospital, Newcastle Hospitals NHS Foundation Trust; Newcastle-upon-Tyne UK

7. Newcastle University; Newcastle-upon-Tyne UK

8. University College London; London UK

9. Great North Children's Hospital; Newcastle Hospitals NHS Foundation Trust; Newcastle-upon-Tyne UK

10. University College London, Great Ormond Street Hospital NHS Foundation Trust; London UK

11. NIHR Great Ormond Street Hospital Biomedical Research Centre; London UK

Funder

National Institute on Handicapped Research

Medical Research Council

National Institute for Health Research

Arthritis Research UK

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference34 articles.

1. National Institute for Health and Care Excellence Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis 2002 https://www.nice.org.uk/guidance/ta35

2. BSPAR standards of care for children and young people with juvenile idiopathic arthritis;Davies;Rheumatology (Oxford),2010

3. How common is remission in juvenile idiopathic arthritis: a systematic review;Shoop-Worrall;Semin Arthritis Rheum,2017

4. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force;Smolen;Ann Rheum Dis,2016

5. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update;Stoffer;Ann Rheum Dis,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3